Search Results 1341-1350 of 18626 for hepatitis

1. Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma - Mayo Clinic

   Known active hepatitis B (e.g., hepatitis B surface antigen [HBsAg] reactive) or hepatitis C (e.g., hepatitis C virus [HCV] ribonucleic acid [RNA] [qualitative] ...

2. A Study to Evaluate the Effectiveness and Safety of Relacorilant - Mayo Clinic

   Has known HIV, hepatitis B, or hepatitis C infection and is taking medication for treatment of HIV, hepatitis B, or hepatitis C infection. Has used mitotane ...

3. Primary sclerosing cholangitis - Doctors and departments - Mayo Clinic

   ... hepatitis, Acute liver failure, Autoimmune hepatitis, Amyloidosis, Nonalcoholic steatohepatitis, Hepatocellular carcinoma, Kidney failure ...

4. A Study of Vutrisiran (ALN-TTRSC02) in Patients with Hereditary Transthyretin Amyloidosis (hATTR Amyloidosis) - Mayo Clinic

   Has known human immunodeficiency virus (HIV), hepatitis C virus (HCV) or hepatitis B virus (HBV) infection. Received an experimental drug within 30 days of ...

5. Alisertib in Treating Patients With Myelofibrosis or Relapsed or Refractory Acute Megakaryoblastic Leukemia - Mayo Clinic

   Patients who have known or suspected active hepatitis C infections are not eligible. NOTE: patients who are hepatitis C surface antigen positive are eligible.

6. Pediatric MSC-AFP Sub-study for Crohn's Fistula - Mayo Clinic

   Evidence of hepatitis B, C, or HIV. History of cancer including melanoma (with the exception of localized skin cancers); Investigational drug within thirty ...

7. Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma (HIMALAYA) - Mayo Clinic

   Patients with HBV infection, characterized by positive hepatitis B surface antigen (HBsAg) and/or hepatitis B core antibodies (anti-HBcAb) with detectable ...

8. A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease - Mayo Clinic

   History of acute/chronic hepatitis B or C and/or carriers of hepatitis B (seropositive for hepatitis B surface antigen [HbsAg] or anti-hepatitis C [HCV] ...

9. Acute Liver Failure Clinical Trials - Mayo Clinic Research

   The primary purpose of this study is to develop an understanding of the prevalence, characteristics, and outcomes of major bleeding and clinically relevant non- ...

10. A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3) - Mayo Clinic

    ... hepatitis B surface antigen or hepatitis C antibodies are allowed provided they do not have active disease requiring antiviral therapy). 10. Myocardial ...